Le Lézard
Classified in: Health, Business
Subjects: NPT, PDT, BFA, TRI, CXP

Clear Thoughts Foundation has created a new collaborative initiative to fund breakthrough discoveries for dementia research in 2020


PITTSBURGH, Dec. 10, 2019 /PRNewswire/ -- It's a disease that has quietly become one of the leading causes of death in the U.S. and world today... dementia. Beginning in January 2020, the Clear Thoughts Foundation is set to fund a new type of collaborative initiative, one that aims to tackle dementia head on. The CTF Consortium is a collaborative group of renowned researchers and doctors from UPMC and University of Pittsburgh, working to cure dementia now! This newly funded initiative will take immediate action with the hopes to offset the staggering statistics of dementia. The CTF Consortium is continuously looking for support that will help fuel this new approach of direct research and collaborative discoveries, as well as aid in improving the breadth and depth at which they discover breakthrough drugs and novel treatments to eliminate this terrible disease.

Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8630351-clear-thoughts-foundation-consortium-dementia-research/

The CTF Consortium is a collaborative group of renowned researchers and doctors from UPMC and University of Pittsburgh, working to cure dementia now!

This newly funded initiative will take immediate action with the hopes to offset the staggering statistics of dementia. The CTF Consortium is continuously looking for support that will help fuel this new approach of direct research and collaborative discoveries, as well as aid in improving the breadth and depth at which they discover breakthrough drugs and novel treatments to eliminate this terrible disease.

Among the inaugural CTF Consortium members are Dr. Robert M. Friedlander, Dr. Oscar L. Lopez, and Dr. Amantha Thathiah. The foundation believes that each member's research dissects and aims to solve an important piece of the puzzle in finding a cure for dementia research.

"We believe that one brilliant mind working towards a cure for dementia is great, but three brilliant minds is 3x as great!" said Hayley D. Jameson, CTF's Founder and President.

In approaching their 10th year as a foundation, CTF wanted to truly enhance their impact on the devastation being cause by this horrific disease. Funding a combination of research focused on drug discovery and therapeutics simultaneously, will allow for faster discoveries to aid not only those being diagnosed with the disease in Pittsburgh, but hopefully those around the world.

"Drug discovery and therapeutics, they go together. Everything that we do in order to enhance these discoveries, is extremely useful. The reason being that we do not have many drugs... and so we still have a lot of work to do. The Consortium is helping the people and scientists to one day have a cure for dementia and Alzheimer's disease," says Inaugural CTF Consortium member Dr. Oscar Lopez.

On Saturday, November 2nd, Clear Thoughts Foundation held its 6th annual Roll for a Reason Gala at J. Verno Studios in the South Side of Pittsburgh. With over 400 supporters in attendance, CTF was able to begin raising the necessary funds to support this new initiative that will expand their mission of funding the fight against dementia. Jameson shared from her heart with guests that evening, "We need to act faster, raise more money, and proceed with relentless passion in this fight against dementia!" Their annual Gala is set for November 7th, 2020 ? save the date and plan to join this amazing night!

For more information, to make a donation, utilize resources, or share your story visit www.clearthoughtsfoundation.org.

About Clear Thoughts Foundation,
Clear Thoughts Foundation, established in 2010, is a nonprofit organization located in Pittsburgh PA. They have a vision to see a world free of dementia and strive to achieve this vision through their mission to raise funds to discover breakthrough drugs and novel treatments to eliminate dementia.

Clear Thoughts Foundation has pledged to take a stand in funding research to fight against all forms of dementia, in contrast to the majority of charitable causes that focus their efforts on targeting a specific dementia disease. While many philanthropic organizations give support for basic research into the causes of the disease, few focus on both breakthrough drug discovery and development of novel treatments (bio-genetics, stem cells, etc.)

Our Guiding CreedFunding is our barrier. Awareness is our opportunity. Research is our salvation. Time is our enemy. YOU are our hope.

Contact:
Clear Thoughts Foundation
[email protected]

 

 

 

SOURCE Clear Thoughts Foundation


These press releases may also interest you

at 12:27
This year marks the 14th anniversary of the enactment of the Affordable Care Act (ACA). Its passage was the most significant advancement of health policy since the establishment of Medicare and Medicaid in the 1960s and made healthcare accessible and...

at 12:15
ResBiotic Nutrition, Inc. (ResBiotic), the pioneering physician-developed pre/probiotic wellness scale-up, proudly announces the appointments of Stefany Nieto as Vice President of Operations and Brittany Zenner as Director of Marketing. Nieto is a...

at 12:06
Maid Sailors Cleaning Service has joined forces with Cleaning for a Reason, a non-profit organization offering free house cleaning services to cancer patients across the United States and Canada....

at 12:05
Terragia Biofuel, a technology startup aiming to drive the next generation of biofuels, today announced it has raised a $6 million seed round led by Engine Ventures and Energy Impact Partners (EIP). The company will use the capital to commercialize...

at 12:05
Float, the marketplace moving all the care that doesn't need a hospital to the home, today announced $10 million in Series A funding led by Canvas Ventures, whose General Partner Mike Ghaffary has joined Float's board, with participation from Wave...

at 12:00
V-Wave today announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American College of Cardiology's (ACC) Annual Scientific Session & Expo taking place April 6-8 in Atlanta. RELIEVE-HF is a randomized, double-blind,...



News published on and distributed by: